Stay informed with the latest updates for the inheritable blood disorders community.

Industry
Shire Submits IND Application for Hemophilia A Gene Therapy Candidate
Shire Submits IND Application for Hemophilia A Gene Therapy Candidate
Industry
Genentech Patient Foundation Responds to NHF-HFA Letter
Genentech Announces Progress in Two Phase III Emicizumab Studies
Advocacy & Legislative
It's Not Too Late: Take Action on Tax Reform
The Senate Bill (BCRA) Will Hurt the Bleeding Disorders Community
NBDF & Community
Green Park Collaborative, National Hemophilia Foundation, McMaster University, Announce Launch of CoreHEM Project
Green Park Collaborative, National…
Medical
Study Yields Important Findings on the Functions of von Willebrand Factor
Partners Relaunches Module on the Fundamentals…
Industry
FDA Accepts License Application and Grants Priority Review for Emicizumab
FDA Approves Biologics License Application for Novo Nordisk’s…
Industry
Investigational Therapy for Hemophilia A Comes up Short in Trial
Investigational Therapy for Hemophilia A Comes up Short in Trial
Advocacy & Legislative
A Million Dollar Patient in Perspective
A Million Dollar Patient in Perspective
Medical
“Hands On” Physicians Workshop Will Tackle Hemophilia and Inhibitors
Medical
Partners Relaunches School Nurse Module on VWD
Partners Relaunches School Nurse Module on VWD
Advocacy & Legislative
Healthcare Reform Update
Healthcare Reform Update
NBDF & Community
9-Year-Old Girl Raises $40,000 at NHF's Red Tie Soiree
9-Year-Old Girl Raises $40,000 at NHF's Red Tie Soiree
Blood Safety
Report Focuses on Two Cases of Sporadic CJD in the UK
Report Focuses on Two Cases of Sporadic CJD in the UK
Medical
Partners Module Offers a Primer for Nurses Interested in Clinical Research
Partners Module Offers a Primer for Nurses Interested in Clinical Research…
Vote on Revived American Health Care Act is Pending: Raise Your Voice in Support of Patient Protections!
Vote on Revived American Health Care Act is…